
Contactless imaging, Norwood/Ludwig staging and large language model (LLM) inference for scalp disease screening, hair health scoring and cosmetic product allergen tracking.
& Cosmetic Allergen Tracking — DermaGuard AI is an AI-powered mobile dermatology platform that evaluates nail and scalp/hair health under a single unified platform. This brochure focuses on the Scalp module. The system non-invasively assesses scalp health, disease screening and cosmetic product allergen tracking from a standard scalp/hair photograph. It analyzes scalp color, density, thickness, sebum, dandruff and hair strands to screen for androgenetic alopecia, alopecia areata, tinea capitis, seborrheic dermatitis, FFA and lichen planopilaris.
Density, thickness, erythema and hair-loss patterns in the scalp alter light reflection/scattering characteristics. The AI quantifies these optical signatures through image processing and spectral analysis to produce a hair health score, Norwood/Ludwig staging, miniaturization score and scarring alopecia assessment.
The platform combines image processing and large language model (LLM)-based multimodal inference. From a standard RGB image, the scalp region is segmented; density, thickness, color and erythema features are extracted and clinical inference is performed with a multimodal LLM.
The analysis provides multi-layer parameters across disease screening, health score and product allergen modules. Each parameter is reported as percentage (0-100), description, severity and risk level.
The platform supports clinical workflows as a screening and pre-triage tool. Scalp parameter mapping provides structured, reproducible and comparable data to the physician. Final diagnosis and treatment decisions always rest with the specialist physician.
The software-centric architecture aligns with European Union carbon-reduction and ESG (Environmental, Social, Governance) goals. Hardware independence brings medical consumable use close to zero and reduces the carbon footprint from patients' physical travel through telemedicine.
The following studies establish the clinical validity and methodological foundations of image-based AI assessment of scalp and hair diseases. Our DermaGuard AI platform draws inspiration from this literature but does not replace these methods.